Investec Bank plc
Incorporated in England and Wales
Registration number 489604
Date: 9 August 2018
Re: Base Prospectus in respect of the £4,000,000,000 Zebra Capital Plans Retail Structured Products Programme (the "Base Prospectus")
The Base Prospectus was approved on 9 August 2018 by the UK Listing Authority and is available for viewing.
A copy of the Base Prospectus is available at:
i. the registered office of the Issuer, Investec Bank plc, at 30 Gresham Street, London EC2V 7QP; and
ii. the office of Deutsche Bank AG London Branch at Winchester House, 1 Great Winchester House, London EC2N 2DB, as Paying Agent in respect of the £4,000,000,000 Zebra Capital Plans Retail Structured Products Programme.
A copy of the Base Prospectus has also been submitted to the National Storage Mechanism and will be available for inspection at: http://www.morningstar.co.uk/uk/NSM.
Please click on the link below to see the full documents:
DISCLAIMER - INTENDED ADDRESSEES
Please note that the information contained in the Base Prospectus, including any document incorporated by reference therein may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom any offer contained in the Base Prospectus is not addressed. Prior to relying on the information contained in the Base Prospectus, you must ascertain from the Base Prospectus whether or not you are one of the intended addressees of the information contained therein.
Your right to access this service is conditional upon complying with the above requirement.
For further information, please contact:
Investec Bank plc
30 Gresham Street
London EC2V 7QP
TEL: (+44) 20 7597 4000
Company No. 489604
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.